The role of the Alzheimer's Association in the genesis of Alzheimer's Disease Neuroimaging Initiative
Open Access
- 6 September 2024
- journal article
- review article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (11) , 8183-8187
Abstract
Here we highlight the Alzheimer's Association's role since its inception, as a strategic collaborator with National Institutes of Health–National Institute on Aging in the development of the modern era of the Alzheimer's Movement and in making Alzheimer's disease (AD) a national priority in the United States by developing several initiatives to advance knowledge about the cause, diagnosis, and treatment of dementia. Among these collaborative undertakings, the Alzheimer's Disease Neuroimaging Initiative (ADNI) is an exemplary case, launched with groundwork by the Neuroimaging Working Group sponsored by the Association's Ronald and Nancy Reagan Research Institute on AD. The unique contribution of the Association to the development of ADNI includes participation as a member of ADNI's Private Partner Scientific Board and involvement in developing an AD biomarker standardization and validation subproject, which has led to a conceptual shift in the field to define AD based on its underlying biology. Furthermore, the creation of Worldwide ADNI (WW‐ADNI) is highlighted, underscoring the global impact of these efforts.Highlights: The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a keystone undertaking in the evolving landscape of Alzheimer's disease (AD) research, and is now in its fourth iteration. The Alzheimer's Association has partnered with ADNI since its inception. ADNI 4 and the Association continue to collaborate, ensuring representation within the study population.Keywords
This publication has 13 references indexed in Scilit:
- The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)Alzheimer's & Dementia, 2023
- Worldwide Alzheimer's Disease Neuroimaging InitiativeAlzheimer's & Dementia, 2012
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- Revision of the criteria for Alzheimer's disease: A symposiumAlzheimer's & Dementia, 2011
- Perspective on the Alzheimer's Disease Neuroimaging Initiative: Progress report and future plansAlzheimer's & Dementia, 2010
- The Alzheimer's Disease Neuroimaging Initiative positron emission tomography coreAlzheimer's & Dementia, 2010
- The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomesAlzheimer's & Dementia, 2010
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004